Calcimimetics in Hypophosphatemic Rickets (CHR)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00844740|
Recruitment Status : Unknown
Verified February 2009 by Children's Mercy Hospital Kansas City.
Recruitment status was: Enrolling by invitation
First Posted : February 16, 2009
Last Update Posted : February 16, 2009
|Condition or disease||Intervention/treatment||Phase|
|Familial Hypophosphatemic Rickets||Drug: Cinacalcet||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||10 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Effect of Cinacalcet on the Long-Term Treatment of Familial Hypophosphatemic Rickets|
|Study Start Date :||February 2009|
|Estimated Primary Completion Date :||June 2010|
Stable patients with XLH already treated with Phosphate and calcitriol will add Cinacalcet to their treatment regimen. Sequential monitoring of blood and urine biochemical variables will follow, based on which adjustments to the doses of the 3 medications will be done.
Stable patients with XLH already treated with Phosphate and calcitriol will add Cinacalcet to their treatment regimen. Sequential monitoring of blood nand urine biochemical variables will follow, based on which adjustments to the doses of the 3 medications will be done.
Other Name: Sensipar
- doses of phosphate and calcitriol required to sustain goals of blood and urine chemistries [ Time Frame: 9 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00844740
|United States, Missouri|
|Children's Mercy Hospital|
|Kansas City, Missouri, United States, 64108|